ArticleBMC gastroenterology2025

Correction: Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway.

Hui Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.